March 13 (Reuters) - Australian Pharmaceutical Industries Ltd (API) :
- CLEAR THAT API'S NBIO TO PURSUE A MERGER OF API AND SIGMA IS UNABLE TO BE TAKEN FORWARD
- IS REVIEWING ITS SHAREHOLDING IN SIGMA WHICH IT ACQUIRED IN LATTER PART OF 2018
- API HAS CLOSED ITS DATA ROOM AND IS REVIEWING ITS SHAREHOLDING IN SIGMA WHICH IT ACQUIRED IN LATTER PART OF 2018
Source text (http//bit.ly/2TAOoZ4)
(([email protected];))
News: SIG Australian Pharmaceutical Industries Updates On Sigma Takeover
Add SIG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.85 |
Change
0.145(5.37%) |
Mkt cap ! $2.300B | |||
| Open | High | Low | Value | Volume |
| $2.74 | $2.88 | $2.74 | $7.302M | 2.589M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 67492 | $2.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.85 | 21132 | 24 |
View Market Depth
| Last trade - 11.39am 28/11/2024 (20 minute delay) ? |
| SIG (ASX) Chart |
